China Biologic sells $315m ADS offering
China Biologic Products, the Nasdaq-listed biopharmaceutical firm, sold an increased offering of American Depositary Shares (ADS) on June 9 to raise $315m, as books closed a day earlier on the back of strong demand.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts